You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦欣生殖(01951.HK)逆漲逾8%成交激增 杭州明年起「試管嬰兒」費用可報銷
阿思達克 11-28 15:07
杭州明年起「試管嬰兒」費用可報銷。錦欣生殖(01951.HK)今天逆市升破10天線(5.32元),最高見5.72元,現報5.55元,逆升8.4%,成交激增至8,151萬股,涉資4.44億元。 據《浙江日報》,由2023年起,參加杭州市商業補充醫療保險「西湖益聯保」的居民,當年度實施輔助生育參保市民,將可獲最高3,000元人民幣報銷。 國家衛健委等17部門於今年8月中旬印發《關於進一步完善和落實積極生育支持措施的指導意見》首次明確,指導地方逐步將適宜分娩鎮痛和輔助生殖技術項目按程序納入醫保(含生育保險)基金支付範圍,之後,各地積極探索和推動將輔助生殖納入醫保。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account